This is first report that aspirin was used as the model drug to encapsulate in MOF.
Two techniques have been demonstrated in delivering drug using a metal-organic framework (MOF) MIL-100(Fe).
First method is the encapsulation of a small molecule drug (aspirin) by the MIL-100(Fe) referred as the ASA@MIL-100(Fe).
The other method is that using de novo synthesis of AH-series MOFs (bio-MOFs) with aspirin was utilized.
Both drug carriers exhibited potential for a sustained delivery in simulated biological fluids for a prolonged period.